Department of Pharmaceutics and Pharmaceutical Chemistry Department Utah Salt Lake City UT 84112 Department of Bioengineering University ofDepartment Utah Salt Lake City UT 84112 Jindrich.Kopecek@m.cc.utah.edu;
Department of Pharmaceutics and Pharmaceutical Chemistry Department Utah Salt Lake City UT 84112 Department of Bioengineering University ofDepartment Utah Salt Lake City UT 84112;
Department of Pharmaceutics and Pharmaceutical Chemistry Department Utah Salt Lake City UT 84112;
Department of Pharmaceutics and Pharmaceutical Chemistry Department Utah Salt Lake City UT 8;
机译:CXCR2大分子复合物在胰腺癌:肿瘤生长的潜在治疗目标。
机译:骨靶向大分子疗法。
机译:大分子疗法:优势和前景,特别是针对实体瘤的靶向。
机译:受体介导的大分子治疗靶向靶向
机译:受体介导的靶向作用可增强化学治疗剂的疗效。
机译:胰腺癌中的CXCR2大分子复合物:肿瘤生长的潜在治疗目标。
机译:胰腺癌中Cxcr2大分子复合物:肿瘤生长的潜在治疗靶点
机译:黄体酮受体介导的乳腺癌细胞周期调控的治疗意义